Hugh M. Davis - Nov 18, 2024 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Matthew Rothman, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Nov 18, 2024
Transactions value $
$0
Form type
3
Date filed
11/18/2024, 04:20 PM
Next filing
Dec 3, 2024

No securities are beneficially owned.